Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill A. Dmitriev, Natalia V. Vostokova, Valeria N. Azarova, Andrew A. Blinow, Alina N. Egorova, Ivan G. Gordeev, Alexey P. Ilin, Ruben N. Karapetian, Dmitry V. Kravchenko, Nikita V. Lomakin, Elena A. Merkulova, Natalia A. Papazova, Elena P. Pavlikova, Nikolay P. Savchuk, Elena N. Simakina, Tagir A. Sitdekov, Elena A. Smolyarchuk, Elena G. Tikhomolova, Elena V. Yakubova, Alexandre V. Ivachtchenko
doi: https://doi.org/10.1101/2020.07.26.20154724
Andrey A. Ivashchenko
1ChemRar High-Tech Center, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirill A. Dmitriev
2Russian Direct Investment Fund, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia V. Vostokova
3IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria N. Azarova
3IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew A. Blinow
4Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alina N. Egorova
3IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan G. Gordeev
5City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexey P. Ilin
6Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruben N. Karapetian
7Department of Biology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dmitry V. Kravchenko
6Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikita V. Lomakin
8Central Clinical Hospital with Polyclinic, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena A. Merkulova
3IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia A. Papazova
9Department of finished dosage forms, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena P. Pavlikova
10Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolay P. Savchuk
11Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena N. Simakina
12Clinical Hospital No.1, Smolensk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tagir A. Sitdekov
2Russian Direct Investment Fund, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena A. Smolyarchuk
13First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena G. Tikhomolova
14Infectious clinical hospital No. 2, Nizhny Novgorod, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena V. Yakubova
4Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre V. Ivachtchenko
11Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: av{at}chemdiv.com nv{at}ipharma.ru
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: August 2020 to July 2025

AbstractFullPdf
Aug 20205403019063
Sep 202013860925
Oct 20205490565
Nov 20203320431
Dec 20202810324
Jan 20213446285
Feb 202139429390
Mar 202131122334
Apr 202130322509
May 20213058508
Jun 202122721237
Jul 202120316237
Aug 202122521246
Sep 202118710178
Oct 20211627154
Nov 20211898128
Dec 202114021128
Jan 20221417147
Feb 20221013107
Mar 202280274
Apr 202288369
May 202292169
Jun 202253259
Jul 2022584342
Aug 202240390
Sep 202280940
Oct 202265334
Nov 202248343
Dec 202272221
Jan 2023462125
Feb 202329723
Mar 202328019
Apr 202338419
May 202338132
Jun 202316524
Jul 202316018
Aug 2023251620
Sep 20232148
Oct 202326217
Nov 202327144
Dec 202329139
Jan 202425028
Feb 202433415
Mar 202436233
Apr 202431623
May 202427727
Jun 202414419
Jul 202442142
Aug 2024261034
Sep 202432326
Oct 202426823
Nov 202431622
Dec 202425927
Jan 202521518
Feb 2025221119
Mar 2025562730
Apr 202537919
May 2025371128
Jun 2025532236
Jul 2025111
Back to top
PreviousNext
Posted August 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Andrey A. Ivashchenko, Kirill A. Dmitriev, Natalia V. Vostokova, Valeria N. Azarova, Andrew A. Blinow, Alina N. Egorova, Ivan G. Gordeev, Alexey P. Ilin, Ruben N. Karapetian, Dmitry V. Kravchenko, Nikita V. Lomakin, Elena A. Merkulova, Natalia A. Papazova, Elena P. Pavlikova, Nikolay P. Savchuk, Elena N. Simakina, Tagir A. Sitdekov, Elena A. Smolyarchuk, Elena G. Tikhomolova, Elena V. Yakubova, Alexandre V. Ivachtchenko
medRxiv 2020.07.26.20154724; doi: https://doi.org/10.1101/2020.07.26.20154724
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Andrey A. Ivashchenko, Kirill A. Dmitriev, Natalia V. Vostokova, Valeria N. Azarova, Andrew A. Blinow, Alina N. Egorova, Ivan G. Gordeev, Alexey P. Ilin, Ruben N. Karapetian, Dmitry V. Kravchenko, Nikita V. Lomakin, Elena A. Merkulova, Natalia A. Papazova, Elena P. Pavlikova, Nikolay P. Savchuk, Elena N. Simakina, Tagir A. Sitdekov, Elena A. Smolyarchuk, Elena G. Tikhomolova, Elena V. Yakubova, Alexandre V. Ivachtchenko
medRxiv 2020.07.26.20154724; doi: https://doi.org/10.1101/2020.07.26.20154724

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)